Development of Novel Multimodal Dextran-Based Theranostic Tracers: Targeting Fibroblast Activation Protein as Proof of Concept

Informazioni relative al progetto

POLYTROP

ID dell’accordo di sovvenzione: 101130787

DOI

10.3030/101130787

Progetto chiuso

Data della firma CE 11 Maggio 2023

Data di avvio 1 Giugno 2023

Data di completamento 31 Maggio 2025

Finanziato da

• Widening participation and spreading excellence

Costo totale

Nessun dato

Contributo UE

€ 169 326,72

Coordinato da

"NATIONAL CENTER FOR SCIENTIFIC RESEARCH ""DEMOKRITOS"""
Greece

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Data Management Plan (1)

Data Management Plan

The Data Management Plan describes the data management life cyclefor all data sets that will be collected, processed or generated by the action. It is adocument describing what data will be collected, processed or generated andfollowing what methodology and standards, whether and how this data will beshared and/or made open, and how it will be curated and preserved.

Documents, reports (1)

Communication, Dissemination & Exploitation Plan

The plan describes the planned measures to maximize the impact ofthe project, including the dissemination and exploitation measures that are planned,and the target group(s) addressed. Regarding communication measures and publicengagement strategy, the aim is to inform and reach out to society and show theactivities performed, and the use and the benefits the project will have for citizens.

Pubblicazioni

Peer reviewed articles (4)

Mixed ligand Re and 99mTc tricarbonyl complexes bearing two important pharmacophores: 2-(4′-aminophenyl)benzothiazole and curcumin

Autori: Alexandros Stouraitis, Marina Sagnou, Barbara Mavroidi, Christos Kiritsis, Antonio Shegani, Catherine Raptopoulou, Vassilis Psycharis, Constantinos Methenitis, Ioannis Pirmettis, Minas Papadopoulos, Maria Pelecanou
Pubblicato in: Inorganica Chimica Acta, Numero 571, 2024, ISSN 0020-1693
Editore: Elsevier BV
DOI: 10.1016/J.ICA.2024.122172

Synthesis and Biological Evaluation of Novel Cationic Rhenium and Technetium-99m Complexes Bearing Quinazoline Derivative for Epidermal Growth Factor Receptor Targeting

Autori: Sotiria Triantopoulou, Ioanna Roupa, Antonio Shegani, Nektarios N. Pirmettis, Georgia I. Terzoudi, Aristeidis Chiotellis, Maria Tolia, John Damilakis, Ioannis Pirmettis, Maria Paravatou-Petsota
Pubblicato in: Pharmaceutics, Numero 16, 2024, ISSN 1999-4923
Editore: MDPI AG
DOI: 10.3390/PHARMACEUTICS16091213

Pharmaceutics

Autori: A. Papasavva, N. N. Pirmettis, A. Shegani, E. Papadopoulou, C. Kiritsis, M. Georgoutsou-Spyridonos, D. C. Mastellos, A. Chiotellis, P. Kyprianidou, M. Pelecanou, M. Papadopoulos, I. Pirmettis
Pubblicato in: Pharmaceutics, 2024, ISSN 1999-4923
Editore: MDPI
DOI: 10.3390/PHARMACEUTICS16091210

Synthesis and characterization of rhenium and Technetium-99 m tricarbonyl and dicarbonyl complexes with quinaldic acid and Arsenic/Phosphorus derivatives

Autori: Charalampos Triantis, Antonio Shegani, Aristeidis Chiotellis, Catherine Raptopoulou, Vassilis Psycharis, Maria Pelecanou, Ioannis Pirmettis, Minas Papadopoulos
Pubblicato in: Polyhedron, Numero 264, 2024, ISSN 0277-5387
Editore: Elsevier BV
DOI: 10.1016/J.POLY.2024.117236